Skinakin Secures £100K to Revolutionize Therapeutic Clothing for Children with Eczema

We are thrilled to announce that Skinakin, the innovative leader in the design and manufacture of therapeutic clothing for children with eczema, has successfully raised £100,000 in new funding. This significant investment is a testament to Skinakin’s commitment to revolutionizing comfort and care for young patients suffering from eczema, ensuring that they experience improved sleep quality and reduced discomfort caused by night-time scratching. The funding will empower the company to further enhance its flagship product, the SkinAkin Onesies, which offer full scratch protection and are intelligently designed to minimize the risk of skin damage during sleep. The company, already celebrated as the Innovate UK Creative Industry Award Winners 2021, is poised to expand its research and development efforts, integrate advanced materials, and scale up production capacity to meet increasing demand. Based in Northern Ireland and serving the UK, Ireland, and beyond, Skinakin is dedicated to making a tangible difference in the lives of children by providing a practical, stylish, and medically sound solution for eczema management. This new capital injection will also facilitate additional collaborations with healthcare professionals and industry experts, driving future innovations and boosting the company's market presence. As Skinakin continues to blend creativity with scientific innovation, they remain focused on their mission to deliver exceptional care through thoughtfully designed therapeutic apparel. The community, investors, and families alike can look forward to the promising advancements on the horizon, marking a new chapter in accessible, child-friendly eczema care.